Heterogeneous treatment effects of sodium-glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population-based cohort study,Alzheimer's & Dementia

当前位置： X-MOL 学术 › Alzheimers Dement. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Heterogeneous treatment effects of sodium-glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population-based cohort study
Alzheimer's & Dementia ( IF 13.0 ) Pub Date : 2024-07-03 , DOI: 10.1002/alz.14048
Huilin Tang ₁ , William T Donahoo ₂ , Mikael Svensson _{1,

3} , C Elizabeth Shaaban _{4,

5} , Glenn Smith _{6,

7} , Michael S Jaffee _{7,

8} , Yu Huang ₉ , Xia Hu ₁₀ , Ying Lu ₁ , Ramzi G Salloum ₉ , Steven T DeKosky _{7,

8} , Jiang Bian ₉ , Jingchuan Guo _{1,

3}

Affiliation

Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, Florida, USA.
Department of Medicine, University of Florida College of Medicine, Gainesville, Florida, USA.
Center for Drug Evaluation and Safety, University of Florida, Gainesville, Florida, USA.
Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Alzheimer's Disease Research Center, University of Pittsburgh, Pennsylvania, USA.
Department of Clinical and Health Psychology, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA.
1Florida Alzheimer's Disease Research Center (ADRC), University of Florida, Gainesville, Florida, USA.
Department of Neurology and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, USA.
Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, USA.
DATA Lab, Department of Computer Science, Rice University, Houston, Texas, USA.

Sodium-glucose cotransporter 2 (SGLT2) inhibitors exhibit potential benefits in reducing dementia risk, yet the optimal beneficiary subgroups remain uncertain.

中文翻译：